The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group (Q28145191)
Jump to navigation
Jump to search
scientific article (publication date: February 2000)
Language | Label | Description | Also known as |
---|---|---|---|
English | The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group |
scientific article (publication date: February 2000) |
Statements
The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group (English)
0 references
February 2000
0 references
129
0 references
2
0 references
136-43
0 references